EMAIL THIS PAGE TO A FRIEND

Molecular oncology

5-Fluorouracil preferentially sensitizes mutant KRAS non-small cell lung carcinoma cells to TRAIL-induced apoptosis.


PMID 26130327

Abstract

Mutations in the KRAS gene are very common in non-small cell lung cancer (NSCLC), but effective therapies targeting KRAS have yet to be developed. Interest in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a potent inducer of cell death, has increased following the observation that TRAIL can selectively kill a wide variety of human cancer cells without killing normal cells both inxa0vitro and in xenograft models. However, results from clinical trials of TRAIL-based therapy are disappointingly modest at best and many have demonstrated a lack of therapeutic benefit. Current research has focused on selecting a subpopulation of cancer patients who may benefit from TRAIL-based therapy and identifying best drugs to work with TRAIL. In the current study, we found that NSCLC cells with a KRAS mutation were highly sensitive to treatment with TRAIL and 5-fluorouracil (5FU). Compared with other chemotherapeutic agents, 5FU displayed the highest synergy with TRAIL in inducing apoptosis in mutant KRAS NSCLC cells. We also found that, on a mechanistic level, 5FU preferentially repressed survivin expression and induced expression of TRAIL death receptor 5 to sensitize NSCLC cells to TRAIL. The combination of low-dose 5FU and TRAIL strongly inhibited xenograft tumor growth in mice. Our results suggest that the combination of TRAIL and 5FU may be beneficial for patients with mutant KRAS NSCLC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA023861
Anti-AFMID antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
HPA026536
Anti-AFMID antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2
SAB1306982
ANTI-AFMID(N-TERMINAL) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
B9304 Anti-Bcl-x antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB3500349
Anti-Bcl-xL antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
GW21157 Anti-BCL2L1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
AV02008
Anti-BCL2L1 antibody produced in rabbit, affinity isolated antibody
AV30475
Anti-BCL2L1 antibody produced in rabbit, IgG fraction of antiserum
SAB2103893
Anti-BCL2L1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB1405469
Anti-BIRC4 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1411890
ANTI-BIRC4 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
GW21154 Anti-Caspase 8 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB3500404
Anti-Caspase-8 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1406737
Anti-CFLAR antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
AV00022
Anti-CFLAR antibody produced in rabbit, IgG fraction of antiserum
SAB2100411
Anti-CFLAR antibody produced in rabbit, affinity isolated antibody, lyophilized powder
HPA019044
Anti-CFLAR antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
SAB3500428
Anti-DR4 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3500429
Anti-FLIP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
AV02065
Anti-TNFRSF10A antibody produced in rabbit, IgG fraction of antiserum
HPA054475
Anti-TNFRSF10A antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
X4503 Anti-XIAP antibody produced in goat, affinity isolated antibody, lyophilized powder
PRS3331
Anti-XIAP antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4501453
Anti-XIAP antibody produced in rabbit, affinity isolated antibody
EHU114431
MISSION® esiRNA, esiRNA human KRAS (esiRNA1)
EMU170821 MISSION® esiRNA, esiRNA targeting mouse Birc5
WH0000598M1
Monoclonal Anti-BCL2L1 antibody produced in mouse, clone 3E2-2A5, purified immunoglobulin, buffered aqueous solution
WH0000331M1
Monoclonal Anti-BIRC4 antibody produced in mouse, clone 2B3, purified immunoglobulin, buffered aqueous solution
SAB1403557
Monoclonal Anti-BIRC4 antibody produced in mouse, clone 1F4, purified immunoglobulin, buffered aqueous solution
SAB5300353 Monoclonal Anti-CASP8 antibody produced in mouse, clone 1H11, ascites fluid